Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for prevention of postoperative anxiety after breast and thyroid surgery
ChiCTR2200060928Phase 4Recruiting
- Sponsor
- Xiangyang Central Hospital
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in anxiety disorder and postoperative pain comparing Esketamine arm with Placebo arm (2 arms). Primary endpoints: Postoperative anxiety score, Postoperative pain at rest and 1 more. Started Jul 2022; status: recruiting.
02
Drugs
esketamine
03
Conditions
anxiety disorderpostoperative pain
Beyond the preview
Go deeper on ChiCTR2200060928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200060928.